Ascendis Pharma A/S
(NASDAQ : ASND)

( )
ASND After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.93%54.040.9%$1956.39m
JNJJohnson & Johnson -0.82%165.210.7%$952.05m
ABBVAbbVie, Inc. -1.62%133.021.9%$896.21m
MRKMerck & Co., Inc. -0.69%80.730.7%$844.40m
BMYBristol-Myers Squibb Co. -0.17%64.611.0%$686.91m
LLYEli Lilly & Co. -0.76%243.201.1%$618.39m
AZNAstraZeneca Plc 1.16%60.171.0%$237.52m
NVSNovartis AG -0.75%88.180.2%$191.03m
GSKGlaxoSmithKline Plc -1.77%44.880.2%$165.07m
NVONovo Nordisk A/S -1.86%95.480.1%$149.54m
VTRSViatris, Inc. -0.54%14.640.0%$136.21m
RGENRepligen Corp. -0.59%188.466.7%$100.63m
ALLKAllakos, Inc. -3.37%7.180.0%$85.67m
IMMXImmix Biopharma, Inc. -4.24%5.420.0%$85.35m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.87%116.040.0%$75.90m

Company Profile

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.